Eric Allan Meyerowitz
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- Modeling and Simulation top 2%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 12
- COVID-19 Clinical Research Studies 11
- SARS-CoV-2 detection and testing 3
- Virology 6
- Poxvirus research and outbreaks 5
- Co-authors
- Aaron G. Richterman (9 shared papers)Rajesh Tim Gandhi (3 shared papers)Paul Edward Sax (2 shared papers)Müge Çevik (5 shared papers)Arthur Y. Kim (3 shared papers)Nicola N Low (2 shared papers)Isaac I. Bogoch (1 shared paper)Esperance A. K. Schaefer (1 shared paper)
- Journals
- Open Forum Infectious Diseases (6 papers)Clinical Infectious Diseases (6 papers)JAMA Network Open (3 papers)New England Journal of Medicine (3 papers)Annals of Internal Medicine (2 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Eric Allan Meyerowitz
38 papers receiving 2.6k citations
Eric Allan Meyerowitz's Hit Papers
Peers
Comparison fields: 5 of 131
- Infectious Diseases 1.4k
- Modeling and Simulation 225
- Neurology 534
- Virology 135
- General Dentistry 23
Countries citing papers authored by Eric Allan Meyerowitz
This map shows the geographic impact of Eric Allan Meyerowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Allan Meyerowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Allan Meyerowitz more than expected).
Fields of papers citing papers by Eric Allan Meyerowitz
This network shows the impact of papers produced by Eric Allan Meyerowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Allan Meyerowitz. The network helps show where Eric Allan Meyerowitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Allan Meyerowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy of Tocilizumab in Patients Hospitalized with Covid-19 Hit paper breakdown → | 2020 | 1049 |
| 2 | Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors Hit paper breakdown → | 2020 | 532 |
| 3 | 2020 | 156 | |
| 4 | 2020 | 121 | |
| 5 | 2022 | 117 | |
| 6 | 2020 | 113 | |
| 7 | 2020 | 107 | |
| 8 | 2020 | 70 | |
| 9 | 2022 | 51 | |
| 10 | 2020 | 39 | |
| 11 | 2020 | 37 | |
| 12 | 2021 | 37 | |
| 13 | 2023 | 32 | |
| 14 | Updated Evidence for COVID-19, RSV, and Influenza Vaccines for 2025-2026 Hit paper breakdown → | 2025 | 30 |
| 15 | 2022 | 19 | |
| 16 | 2021 | 16 | |
| 17 | 2020 | 15 | |
| 18 | 2023 | 14 | |
| 19 | 2023 | 13 | |
| 20 | 2022 | 12 |
About Eric Allan Meyerowitz
Eric Allan Meyerowitz is a scholar working on Infectious Diseases, Virology, Modeling and Simulation, Neurology and Epidemiology, having authored 39 papers that have together received 2.6k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (12 papers), COVID-19 Clinical Research Studies (11 papers), Poxvirus research and outbreaks (5 papers), COVID-19 epidemiological studies (4 papers), Long-Term Effects of COVID-19 (4 papers), Infection Control and Ventilation (3 papers), SARS-CoV-2 detection and testing (3 papers) and Herpesvirus Infections and Treatments (3 papers). The work is most often cited by research in Infectious Diseases (1.4k citations), Modeling and Simulation (225 citations), Neurology (534 citations), Virology (135 citations) and General Dentistry (23 citations). Eric Allan Meyerowitz has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Aaron G. Richterman, Rajesh Tim Gandhi, Paul Edward Sax, Müge Çevik, Arthur Y. Kim, Nicola N Low, Isaac I. Bogoch, Esperance A. K. Schaefer, Jenna L. Gustafson and Patricia Pringle Bloom. Their work appears in journals such as Open Forum Infectious Diseases, Clinical Infectious Diseases, JAMA Network Open, New England Journal of Medicine and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.